Plasminogen activator inhibitor-1 (PAI-1) is frequently expressed in both primary and metastatic melanoma lesions, with particularly high expression in cutaneous metastases correlating with increased invasiveness and motility, implicating PAI-1 in risk stratification for metastasis [23]. Here, SERPINE1 is linked to metastatic melanoma.